LCYB DID NOT ask BioAmber to assure anything and I know for a fact you can not show they did. LCYB send to have the Reverdia licensed tech transferred to LCYB and they were going to pay the back royalties which were app $408,000. Then in the end LCYB opted out of the STA and decided they did not want to pay the back royalties. LCYB NEVER asked BioAmber to assure anything in fact it was Reverdia they asked in the beginning to have the rights to the tech transferred to them but then decided not to. So there was nothing ever asked of BioAmber and it was also never stated that it was essential to running the plant.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.